EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Comparing the risk of severe oral mucositis associated with methotrexate as graft-versus host-disease prophylaxis to other immunosuppressive prophylactic agents in hematopoietic cell transplantation: a systematic review and meta-analysis

Aisha A H Al-Jamaei, Joel B Epstein, Jan G A M de Visscher, Ricardo T Spielberger, Ryotaro Nakamura, Judith E Raber-Durlacher

Supportive Care in Cancer · 2024

DOI: 10.1007/s00520-024-08722-w ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Aisha A H Al-Jamaei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Amsterdam UMC, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Immunosuppressive Agents, Methotrexate. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study examines the risk of severe oral mucositis (SOM) in graft-versus-host disease prophylaxis (GVHD) compared to other agents in hematopoietic cell transplantation patients.

Methods

A comprehensive search of four databases, including PubMed, Embassy, Web of Science, and Scopus, was conducted to identify studies reporting frequency and severity of oral mucositis in association with GVHD prophylactic regimens. RevMan 5.4 was used to perform the meta-analysis. Risk of bias assessment was carried out using the Rob-2 tool for randomized clinical trials (RCTs) and ROBINS-I tool for observational studies.

Results

Twenty-five papers, including 11 RCTs and 14 observational studies, met the inclusion criteria. The pooled results from eight RCTs showed a higher risk of SOM in patients receiving MTX or MTX-inclusive GVHD prophylaxis versus non-MTX alternatives (RR = 1.50, 95% CI [1.20, 1.87], I 2 = 36%, P = 0.0003). Mycophenolate mofetil (MMF) and post-transplant cyclophosphamide (Pt-Cy) consistently showed lower risk of mucositis than MTX. Folinic acid (FA) rescue and mini-dosing of MTX were associated with reduced oral mucositis severity.

Conclusion

Patients receiving MTX have a higher SOM risk compared to other approaches to prevent GVHD, which should be considered in patient care. When appropriate, MMF, FA, and a mini-dose of MTX may be an alternative that is associated with less SOM. This work also underlines the scarcity of RCTs on MTX interventions to provide the best evidence-based recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationImmunosuppressive AgentsMethotrexateStomatitisHumansRandomized Controlled Trials as TopicSeverity of Illness Index

Stichwörter der Autor:innen

Graft versus host diseaseHCTHematopoietic cell transplantationMethotrexateOral mucositis

Substanzen

Immunosuppressive AgentsMethotrexate

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Amsterdam UMC, Amsterdam, The Netherlands.
  • Department of Oral Medicine, Periodontics, Diagnostic, and Oral Radiology, Faculty of Dentistry, Sanaá University, Sanaá, Yemen.
  • Department of Oral Surgery and Oral Medicine, Al-Razi University, Sanaá, Yemen.
  • Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Department of BMT, Southern California Permanente Medical Group, Kaiser Permanente, Los Angeles, CA, USA.

Zitieren

APA

Al-Jamaei, A. A. H., Epstein, J. B., de Visscher, J. G. A. M., Spielberger, R. T., Nakamura, R., & Raber-Durlacher, J. E. (2024). Comparing the risk of severe oral mucositis associated with methotrexate as graft-versus host-disease prophylaxis to other immunosuppressive prophylactic agents in hematopoietic cell transplantation: a systematic review and meta-analysis. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08722-w

Vancouver

Al-Jamaei AAH, Epstein JB, de Visscher JGAM, Spielberger RT, Nakamura R, Raber-Durlacher JE. Comparing the risk of severe oral mucositis associated with methotrexate as graft-versus host-disease prophylaxis to other immunosuppressive prophylactic agents in hematopoietic cell transplantation: a systematic review and meta-analysis. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08722-w

BibTeX
@article{AlJamaei2024,
  author = {Al-Jamaei, Aisha A H and Epstein, Joel B and de Visscher, Jan G A M and Spielberger, Ricardo T and Nakamura, Ryotaro and Raber-Durlacher, Judith E},
  title = {Comparing the risk of severe oral mucositis associated with methotrexate as graft-versus host-disease prophylaxis to other immunosuppressive prophylactic agents in hematopoietic cell transplantation: a systematic review and meta-analysis},
  journal = {Supportive Care in Cancer},
  year = {2024},
  doi = {10.1007/s00520-024-08722-w}
}
Kostenlos starten →